InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Wednesday, 03/20/2019 4:18:45 PM

Wednesday, March 20, 2019 4:18:45 PM

Post# of 5918
This reminds me of GWPH monster move that happened a few years back:

The success of GW in developing pharmaceutical drugs from marijuana sent its shares from less than $9 in 2013 to more than $110 in 2016 and earned it a market value of more than $2.9 billion. And has almost doubled again.

I believe the Zynerba Pharma pipeline is comparable and as deep as GWPH. Exciting times ahead.

Armando the CEO has sold two other biotech companies for north of a billion each.

No Debt

60 Million in cash

The 21 million shares makes ZYNE shares very scarce and the possibility for a blue sky break out in the near future many catalysts.


http://ir.zynerba.com/static-files/1a4c0483-3e61-43d7-a160-ddfc45f68b64

Long
$ZYNE
&
$GWPH